Ovarian Cyst

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Ovarian Cyst

MalaCards integrated aliases for Ovarian Cyst:

Name: Ovarian Cyst 11 5 14 75
Ovarian Cysts 53 41 14 71


External Ids:

Disease Ontology 11 DOID:5119
ICD9CM 34 620.2
SNOMED-CT 68 198586000
ICD10 31 N83.2
UMLS 71 C0029513 C0029927

Summaries for Ovarian Cyst

MedlinePlus: 41 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include: Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary: Ovarian Cyst, also known as ovarian cysts, is related to corpus luteum cyst and dermoid cyst of ovary, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MSH2 (MutS Homolog 2), and among its related pathways/superpathways are Integrated breast cancer pathway and Glucocorticoid receptor regulatory network. The drugs Letrozole and Etoricoxib have been mentioned in the context of this disorder. Affiliated tissues include ovary, b cells and uterus, and related phenotypes are homeostasis/metabolism and neoplasm

Disease Ontology: 11 An ovarian disease that is characterized by the presence of a fluid-filled sac and is located in the ovary.

Wikipedia: 75 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Related Diseases for Ovarian Cyst

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 516)
# Related Disease Score Top Affiliating Genes
1 corpus luteum cyst 32.4 MUC16 GNRH1 AFP
2 dermoid cyst of ovary 30.8 AMH AFP
3 cystadenoma 30.7 MUC16 MUC1 GNAS BRCA1 AFP
4 cystic teratoma 30.5 MUC1 AMH AFP
5 leiomyoma 30.5 GNRH1 ESR2 ESR1 CYP19A1
6 ovarian serous cystadenocarcinoma 30.5 MUC16 MUC1 GNAS BRCA1
7 ectopic pregnancy 30.4 PAEP GNRH1 CGA AMH AFP
8 fibroma 30.4 MUC16 GNAS ESR1
9 leiomyoma, uterine 30.4 GNRH1 ESR2 ESR1 CYP19A1
10 amenorrhea 30.3 SHBG PRL GNRH1 CYP19A1
11 juvenile type testicular granulosa cell tumor 30.3 GNAS AMH AFP
12 teratoma 30.3 MUC1 ESR1 CGA AMH AFP
13 precocious puberty, male-limited 30.2 GNRH1 GNAS CYP19A1 AMH
14 pseudomyxoma peritonei 30.2 MUC16 MUC1 GNAS
15 adenomyosis 30.2 MUC16 ESR1 CYP19A1
16 lipoid congenital adrenal hyperplasia 30.2 SHBG PRL GNRH1 CYP19A1 AMH
17 mucinous ovarian cystadenoma 30.1 WFDC2 AFP
18 adenoma 30.1 PRL MUC1 MSH2 GNAS
19 endometriosis 30.1 PAEP MUC16 GNRH1 ESR2 ESR1 CYP19A1
20 ovarian hyperstimulation syndrome 30.0 SHBG GNRH1 CYP19A1 CGA AMH
21 myoma 30.0 PRL GNRH1 ESR1 CYP19A1 AMH
22 inguinal hernia 30.0 GNRH1 CRP AMH AFP
23 ovarian cystadenoma 30.0 WFDC2 MUC16 BRCA1 AFP
24 pseudohermaphroditism 30.0 GNRH1 CYP19A1 AMH
25 dysgerminoma 30.0 MUC1 BRCA1 AFP
26 pituitary adenoma 29.9 PRL GNRH1 GNAS CNC2
27 cystadenocarcinoma 29.9 MUC16 MUC1 ESR2 BRCA1
28 pituitary tumors 29.9 PRL GNAS CNC2
29 tuberculous peritonitis 29.9 MUC16 CRP AFP
30 hyperandrogenism 29.9 SHBG PRL GNRH1 CYP19A1 AMH
31 premature ovarian failure 1 29.9 PRL GNRH1 AMH
32 endosalpingiosis 29.9 ESR1 BRCA1
33 obstructive jaundice 29.9 MUC16 CRP AFP
34 abdominal tuberculosis 29.9 CRP AFP
35 vaginal discharge 29.8 GNRH1 ESR1 CYP19A1 CRP
36 endometrial hyperplasia 29.8 MSH2 ESR2 ESR1 CYP19A1
37 pituitary gland disease 29.7 PRL GNRH1 GNAS CGA
38 serous cystadenocarcinoma 29.7 MUC16 MSH2 ESR1 BRCA1
39 congenital hypothyroidism 29.7 SHBG PRL GNAS AFP
40 wilms tumor 1 29.7 MUC1 ESR1 BRCA1 AFP
41 female breast cancer 29.6 ESR2 ESR1 CYP19A1 BRCA1
42 endometriosis of ovary 29.6 GNRH1 ESR2 ESR1 CYP19A1 AMH
43 testicular torsion 29.6 SHBG CRP AMH AFP
44 insulin-like growth factor i 29.6 SHBG PRL IGFBP2 ESR1
45 colon adenocarcinoma 29.6 GNAS ESR2 ESR1 CEACAM7
46 ovarian cystadenocarcinoma 29.6 MUC16 MUC1 GNAS ESR1 BRCA1
47 ovary adenocarcinoma 29.6 MUC16 MUC1 GNAS ESR1 BRCA1
48 acne 29.5 SHBG PRL CYP19A1 CRP
49 hyperprolactinemia 29.5 SHBG PRL GNRH1 GNAS CGA
50 hypothyroidism 29.5 SHBG PRL GNRH1 GNAS CRP CGA

Graphical network of the top 20 diseases related to Ovarian Cyst:

Diseases related to Ovarian Cyst

Symptoms & Phenotypes for Ovarian Cyst

UMLS symptoms related to Ovarian Cyst:

pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.24 AFP AMH BRCA1 CEACAM7 CGA CRP
2 neoplasm MP:0002006 10.16 AFP AMH BRCA1 ESR1 ESR2 GNAS
3 normal MP:0002873 10.09 BRCA1 CEACAM7 CYP19A1 ESR1 ESR2 GNAS
4 liver/biliary system MP:0005370 10.06 AFP CYP19A1 ESR1 ESR2 GNAS GNRH1
5 endocrine/exocrine gland MP:0005379 10.06 AFP AMH BRCA1 CGA CYP19A1 ESR1
6 immune system MP:0005387 9.93 BRCA1 CEACAM7 CRP CYP19A1 ESR1 ESR2
7 digestive/alimentary MP:0005381 9.86 BRCA1 CYP19A1 ESR1 ESR2 GNAS GNRH1
8 reproductive system MP:0005389 9.65 AFP AMH BRCA1 CGA CYP19A1 ESR1
9 integument MP:0010771 9.32 BRCA1 CEACAM7 CYP19A1 ESR1 ESR2 GNAS

Drugs & Therapeutics for Ovarian Cyst

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 77)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Letrozole Approved, Investigational Phase 4 112809-51-5 3902
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
Danazol Approved Phase 4 17230-88-5 28417
Cetrorelix Approved, Investigational Phase 4 120287-85-6 25074887
Ganirelix Approved Phase 4 124904-93-4 44208957 16186319 16130966
Norethisterone Approved Phase 4 68-22-4 199472 6230
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
8 Analgesics Phase 4
9 Estrogen Receptor Antagonists Phase 4
10 Estrogen Antagonists Phase 4
11 Aromatase Inhibitors Phase 4
12 Antirheumatic Agents Phase 4
13 Cyclooxygenase Inhibitors Phase 4
14 Cyclooxygenase 2 Inhibitors Phase 4
15 Anti-Inflammatory Agents, Non-Steroidal Phase 4
16 Analgesics, Non-Narcotic Phase 4
17 Fenugreek seed meal Phase 4
18 Fenugreek Phase 4
19 Contraceptives, Oral Phase 4
20 Contraceptive Agents Phase 4
21 Contraceptives, Oral, Hormonal Phase 4
Norethindrone Acetate Phase 4 541197
Ethinylestradiol Approved Phase 2, Phase 3 57-63-6 5991
Norgestimate Approved, Investigational Phase 2, Phase 3 35189-28-7 6540478
Ropivacaine Approved Phase 3 84057-95-4 71273 175805
Morphine Approved, Investigational Phase 3 57-27-2 5288826
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
Polyestradiol phosphate Approved Phase 3 28014-46-2
29 Anesthetics Phase 3
30 Anesthetics, Local Phase 3
31 Estradiol 3-benzoate Phase 3
32 Estradiol 17 beta-cypionate Phase 3
33 Contraceptives, Oral, Combined Phase 3
34 Hormones Phase 3
35 Estrogens Phase 3
36 Hormone Antagonists Phase 3
37 Progestins Phase 3
Racephedrine Approved, Experimental Phase 1, Phase 2 299-42-3, 90-82-4, 90-81-3 5032 9294 7028
Esmolol Approved, Withdrawn Phase 1, Phase 2 103598-03-4, 81147-92-4 59768
Phenylephrine Approved Phase 1, Phase 2 59-42-7 6041
Oxymetazoline Approved, Investigational Phase 1, Phase 2 1491-59-4 4636
42 Neurotransmitter Agents Phase 1, Phase 2
43 Cardiotonic Agents Phase 1, Phase 2
44 Adrenergic beta-Antagonists Phase 1, Phase 2
45 Adrenergic beta-1 Receptor Antagonists Phase 1, Phase 2
46 Adrenergic Antagonists Phase 1, Phase 2
47 Adrenergic alpha-Agonists Phase 1, Phase 2
48 Adrenergic Agonists Phase 1, Phase 2
49 Adrenergic Agents Phase 1, Phase 2
50 Vasoconstrictor Agents Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 55)
# Name Status NCT ID Phase Drugs
1 The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Unknown status NCT01631253 Phase 4
2 The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Completed NCT01999569 Phase 4 Letrozole
3 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc Completed NCT00713778 Phase 4
4 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
5 Treatment With Danazol Before Controlled Ovarian Hyperstimulation in Women With Endometriosis Undergoing IVF Completed NCT01779232 Phase 4 Danazol;placebo
6 Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
7 A Random Clinical Trial of the Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Completed NCT00746278 Phase 4
8 GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst - A Proof-of-concept Pilot Study Recruiting NCT04993924 Phase 4 Cetrorelix Acetate, Ganerelix Acetate
9 Randomized Control Trial Between Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts Not yet recruiting NCT05293574 Phase 4 norethisterone acetate
10 Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women? (Randomized Controlled Study) Unknown status NCT03357640 Phase 2, Phase 3 combined oral contraceptive pills
11 Additional Benefit of Hemostatic Sealant in Preserving Ovarian Reserve During Laparoscopic Ovarian Cystectomy: a Randomized Controlled Trial Completed NCT01857466 Phase 3
12 Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery? Completed NCT01142622 Phase 3 Ropivacaine nebulization;Ropivacaine instillation
13 A Single Center, Randomized, Investigator-initiated Phase III Trial to Evaluate the Efficacy of Preservation of Ovarian Function and Hemostasis, and Its Safety of [email protected] During Laparoscopic Ovarian Cystectomy Completed NCT03374397 Phase 3 Surgiguard
14 Single Port Laparoscopy Versus Conventional Laparoscopy for Benign Adnexal Disease - A Randomized Controlled Trial. Completed NCT01288599 Phase 3
15 Treatment of Functional Ovarian Cyst Randomised Clinical Trial Not yet recruiting NCT05244811 Phase 3 Combined Oral Contraceptive;Progestin
16 A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery Suspended NCT00865488 Phase 3
17 The Effects of ß1-receptor Blockade and α1-adrenergic Agonist on the Kinetics of Lactated Ringer's Solution During Surgery Completed NCT01431612 Phase 1, Phase 2 Esmolol administration;Phenylephrine infusion;Lactated Ringer´s solution
18 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts: Randomization Clinical Trial Unknown status NCT03585309
19 Monitoring Ovarian Cysts in Pregnancy Unknown status NCT03440931
20 A Multicentre Study to Examine the Short and Long Term Outcomes of the Conservative Management of Benign-looking Adnexal Masses and the Pre-operative Characterisation of Ovarian Tumours Unknown status NCT01698632
21 A New Algorithm to Predict Ovarian Age Combining Clinical, Biochemical and 3D-ultrasonographic Parameters: OvAge Unknown status NCT02086318
22 Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst Unknown status NCT02482467
23 The Efficacy of Progestins in Treatment of Functional Ovarian Cyst Unknown status NCT03456570 Early Phase 1 Dydrogesterone 10 mg;Placebo Oral Tablet
24 Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis Completed NCT03193671
25 Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion Completed NCT00222066
26 The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve : A Prospective Study Completed NCT02852447
27 23 Hour Surgical Model in a Tertiary Hospital: Evaluation From Patient and Organisational Perspective Completed NCT04142203
28 Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients Completed NCT02129036
29 The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types Completed NCT05054946
30 Mesial Incision for Laparoscopic Dermoid Cystectomy: a New Safe and Fertility-sparing Technique Completed NCT01590030
31 Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH Completed NCT03370952
32 Transvaginal Ultrasound Training for the Obstetrics and Gynecology Resident: A Multi-Site Randomized Controlled Trial of Educational DVD Completed NCT02890914
33 Ultrasonographic Evaluation of Ovarian Stroma in PCOS Women Completed NCT05418595
34 Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome Completed NCT03713138
35 To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS) Completed NCT02703064
36 The Affect of Hemostasis With Bipolar Coagulation Versus SURGIFLO Placement on Ovarian Reserve and Future Fertility Completed NCT03109964
37 Comparison of Optic Nerve Sheath Diameter According to Position During Laparoscopy Completed NCT01937104 Desflurane;Remifentanil
38 The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position Completed NCT01379313
39 A Prospective, Multi-Centre, Randomized, Safety and Effectiveness Study of PerClot Compared to Usual Care When Used During Gynaecology Procedures Completed NCT02835391
40 3-dimensional Versus 2-dimensional Laparoscopy Of Ovarian Cyst (LOOC): a Randomized Controlled Trial Completed NCT03453333
41 Diagnosing Ovarian Cysts - the DOC Study Recruiting NCT04188652
42 Ultrasound Elastography in Differentiation of Endometriomas and Hemorrhagic Ovarian Cysts Recruiting NCT05104086
43 Intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy (UGLOC) as a Method of Fertility Preservation in the Management of Benign Ovarian Cysts: Randomised Controlled Trial Recruiting NCT05032846
44 Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy Recruiting NCT04355312
45 A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications Recruiting NCT02831556
46 Ovarian Cyst's Enucleation Spillage Score. An Observational Study of Cyst Characteristics for Spillage During Laparoscopic Enucleation Recruiting NCT05376384
47 Real-Time Identification of Lesions and Nerves by Using Indocyanine Green Fluorescent Imaging in Gynecological Surgery Recruiting NCT04224467
48 A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma Recruiting NCT04643106
49 Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst Recruiting NCT04526392
50 Prediction of Malignant Potential of Ovarian Cysts Using Machine Learning Models Not yet recruiting NCT05342298

Search NIH Clinical Center for Ovarian Cyst

Genetic Tests for Ovarian Cyst

Anatomical Context for Ovarian Cyst

Organs/tissues related to Ovarian Cyst:

FMA: Ovary
MalaCards : Ovary, B Cells, Uterus, Breast, Pituitary, Appendix, Small Intestine

Publications for Ovarian Cyst

Articles related to Ovarian Cyst:

(show top 50) (show all 5144)
# Title Authors PMID Year
Comparison of immunohistochemical characteristics of endometriomas with non-endometriotic benign ovarian cysts. 62 41
36314331 2022
Distinct clinicopathological features of ovarian endometriosis after long-term exposure to mifepristone. 41
36348508 2022
Clinical outcomes of fetal ovarian masses diagnosed by prenatal ultrasonography and literature review. 41
36254031 2022
Reproductive disturbances in multiple neuroendocrine tumor syndromes. 53 62
19737912 2009
Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. 53 62
19844120 2009
Precocious pseudopuberty due to autonomous ovarian cysts: a report of ten cases and long-term follow-up. 53 62
18477555 2008
The impact of unabated stimulation by human chorionic gonadotropin on the steroid hormone environment of pregnant rats and the spontaneous expression of ovarian cysts in female progeny. 53 62
18481228 2008
McCune-Albright syndrome and disorders due to activating mutations of GNAS1. 53 62
17937059 2007
Myxedema ascites with an extremely elevated CA125 Level: a case report. 53 62
17641444 2007
Involvement of plasma progesterone, oestradiol-17beta and cortisol in ovulatory response to gonadotropin-releasing hormone in dairy cows with cystic follicles. 53 62
17635773 2007
Obligatory roles for follicle-stimulating hormone (FSH), estradiol and androgens in the induction of small polyfollicular ovarian cysts in hypophysectomized immature rats. 53 62
17873331 2007
Association between milk production and treatment response of ovarian cysts in lactating dairy cows using the Ovsynch protocol. 53 62
16650468 2006
Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. 53 62
16357519 2006
Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer. 53 62
16033074 2005
Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. 53 62
16033064 2005
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. 53 62
15695318 2005
[Carney complex: a case report and literature review]. 53 62
15761519 2004
Intracystic evaluation of tumor markers in benign and malignant ovarian pathology. 53 62
12013118 2002
The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration. 53 62
11473966 2001
Factors influencing serum CA125II levels in healthy postmenopausal women. 53 62
11352859 2001
Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. 53 62
11095480 2000
Serum CA125 at 11-14 weeks of gestation in women with morphologically normal ovaries. 53 62
10826587 2000
Synergistic effects of insulin-like growth factor-I and human chorionic gonadotropin in the rat ovary. 53 62
10726907 2000
Insulin has a biphasic effect on the ability of human chorionic gonadotropin to induce ovarian cysts in the rat. 53 62
10459564 1999
Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area. 53 62
10430190 1999
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. 53 62
9850067 1998
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. 53 62
9866068 1998
CA-125 and carcinoembryonic antigen assay vs. cytodiagnostic experience in the classification of benign ovarian cysts. 53 62
9305384 1997
[A patient with bronchial asthma and mucoid impaction who presented with a high concentration of carcinoembryonic antigen in serum]. 53 62
9366164 1997
Inhibin assays of ovarian cyst liquid obtained by needle aspiration may allow differential diagnosis between functional and organic cysts. 53 62
9228498 1997
The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome. 53 62
9174850 1997
The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment. 53 62
9443032 1997
Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. 53 62
8988701 1997
Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. 53 62
8624265 1996
[Hydatidiform mole in Vietnam. The contribution of ultrasonography]. 53 62
7899773 1995
Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists. 53 62
8187299 1994
Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. 53 62
1640871 1992
Serous ovarian cyst fluids contain high levels of endometrial placental protein 14. 53 62
1626182 1992
Circulating hormone concentrations in hypothyroid rats with induced polycystic ovaries. 53 62
1924408 1991
Effect of intracavitary radiotherapy on tumor-associated trypsin inhibitor (TATI) in patients with cervical and endometrial cancer. 53 62
2354815 1990
Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology. 53 62
1696873 1990
A case of endometriotic cyst enlargement during pregnancy owing to desmoplasia and rupture at 36 weeks of gestation. 62
36439931 2023
Recognizing the features of Isolated Fallopian Tube Torsion on CT and MRI and interobserver agreement: A cross-sectional study. 62
36410090 2022
Gangrenous Hydrosalpinx with Isolated Fallopian Tube Torsion in Premenarchal Child. 62
36457430 2022
Claudin-6 enhances the malignant progression of gestational trophoblastic neoplasm by promoting proliferation and metastasis. 62
36471225 2022
Acute epiploic appendagitis - a rare differential diagnosis of acute abdomen. 62
36470286 2022
Atypical Presentation of a Giant Hemorrhagic Ovarian Cyst. 62
36452449 2022
Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI). 62
36057322 2022
A curious case of ovarian cysts. 62
36412944 2022
A Challenging Case of Fertility Preservation in Metastatic Struma Ovarii in a 29-Year Old With Successful Delivery. 62
36457444 2022

Variations for Ovarian Cyst

ClinVar genetic disease variations for Ovarian Cyst:

# Gene Name Type Significance ClinVarId dbSNP ID Position
1 MSH2 NM_000251.3(MSH2):c.1226_1227del (p.Gln409fs) DEL Pathogenic
90577 rs63750086 GRCh37: 2:47657030-47657031
GRCh38: 2:47429891-47429892

Expression for Ovarian Cyst

Search GEO for disease gene expression data for Ovarian Cyst.

Pathways for Ovarian Cyst

GO Terms for Ovarian Cyst

Cellular components related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.98 WFDC2 PRL PAEP MUC16 MUC1 IGFBP2
2 extracellular region GO:0005576 9.68 AFP AMH CEACAM7 CGA CRP GNAS

Biological processes related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to estrogen GO:0043627 9.1 IGFBP2 ESR1 BRCA1

Molecular functions related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.76 PRL GNRH1 CGA AMH
2 estrogen response element binding GO:0034056 9.56 ESR2 ESR1
3 steroid binding GO:0005496 9.43 SHBG ESR2 ESR1
4 nuclear estrogen receptor activity GO:0030284 8.92 ESR2 ESR1

Sources for Ovarian Cyst

8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
27 GO
28 GTR
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
36 LifeMap
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....